Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.
OBJECTIVE
To determine the features predictive of time to integument damage in patients with systemic lupus erythematosus (SLE) from a multiethnic cohort (LUpus in MInorities, NAture versus nurture [LUMINA]).


METHODS
LUMINA SLE patients (n = 580) age > or =16 years, with a disease duration of < or =5 years at baseline (T0), of African American, Hispanic, and Caucasian ethnicity were studied. Integument damage was defined per the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (scarring alopecia, extensive skin scarring, and skin ulcers lasting at least 6 months); factors associated with time to its occurrence were examined by Cox proportional univariable and multivariable (main model) hazards regression analyses. Two alternative models were also examined: in model 1, all patients, regardless of when integument damage occurred (n = 94), were included; in model 2, a time-varying approach (generalized estimating equation) was employed.


RESULTS
Thirty-nine (6.7%) of 580 patients developed integument damage over a mean +/- SD total disease duration of 5.9 +/- 3.7 years, and were included in the main multivariable regression model. After adjusting for discoid rash, nailfold infarcts, photosensitivity, and Raynaud's phenomenon (significant in the univariable analyses), disease activity over time (hazard ratio [HR] 1.17, 95% confidence interval [95% CI] 1.09-1.26) was associated with a shorter time to integument damage, whereas hydroxychloroquine use (HR 0.23, 95% CI 0.12-0.47) and Texan-Hispanic (HR 0.35, 95% CI 0.14-0.87) and Caucasian ethnicities (HR 0.37, 95% CI 0.14-0.99) were associated with a longer time. Results of the alternative models were consistent with those of the main model, although in model 2, the association with hydroxychloroquine was not significant.


CONCLUSIONS
Our data indicate that hydroxychloroquine use is possibly associated with a delay in integument damage development in patients with SLE.
Pons-Estel
Guillermo J
GJ
University of Alabama at Birmingham, USA.
Alarcón
Graciela S
GS
González
Luis A
LA
Zhang
Jie
J
Vilá
Luis M
LM
Reveille
John D
JD
McGwin
Gerald
G
D000328:Adult; D001741:Black or African American; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006630:Hispanic or Latino; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use*; D053208:Kaplan-Meier Estimate; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy* / Q000208:ethnology; D008297:Male; D012871:Skin Diseases / Q000150:complications / Q000208:ethnology / Q000517:prevention & control*; D044465:White People; D055815:Young Adult
D018501:Antirheumatic Agents; D006886:Hydroxychloroquine
J Rheumatol. 2003 Jul;30(7):1513-9
12858450
Arthritis Rheum. 2001 Dec;44(12):2797-806
11762940
Lupus. 2007;16(12):997-1000
18042596
Lupus. 2002;11(6):356-61
12139373
Lupus. 2007;16(2):89-94
17402364
Arthritis Rheum. 1989 Sep;32(9):1107-18
2775320
Arthritis Rheum. 1990 Feb;33(2):281-6
2306296
J Rheumatol. 2003 Sep;30(9):1955-9
12966597
Lupus. 2003;12(10):788-94
14596430
Am J Epidemiol. 2008 May 1;167(9):1120-9
18334500
Thromb Haemost. 1993 Nov 15;70(5):787-93
8128436
J Clin Epidemiol. 2006 May;59(5):437-47
16632131
J Psychosom Res. 1993 Jan;37(1):53-62
8421260
Medicine (Baltimore). 2006 Jul;85(4):221-228
16862047
J Invest Dermatol. 2005 Nov;125(5):889-94
16297185
Acta Derm Venereol. 1995 May;75(3):228-31
7653184
Am J Clin Pathol. 1990 Oct;94(4):476-84
2220676
Rheumatology (Oxford). 2009 Jun;48(6):673-5
19359343
Ann Rheum Dis. 2007 Sep;66(9):1168-72
17389655
Arthritis Rheum. 2005 May;52(5):1473-80
15880829
Lupus. 1998;7(2):80-5
9541091
Arthritis Rheum. 1996 Mar;39(3):363-9
8607884
Br J Med Psychol. 1997 Jun;70 ( Pt 2):113-47
9210990
Arthritis Rheum. 2007 Aug 15;57(6):993-9
17665464
Arthritis Rheum. 1997 Sep;40(9):1725
9324032
J Rheumatol. 2000 Mar;27(3):680-4
10743808
J Rheumatol. 1998 Sep;25(9):1716-9
9733451
Arthritis Rheum. 1988 Apr;31(4):496-505
2451920
Arthritis Rheum. 1982 Nov;25(11):1271-7
7138600
Lupus. 2002;11(3):152-60
12004788
Rheumatology (Oxford). 2001 Jan;40(1):37-47
11157140
Lupus. 2006;15(8):532-40
16942007
Rheumatol Int. 2007 Mar;27(5):483-7
17033832
Clin Rheumatol. 2005 Aug;24(4):377-80
15599643
Lupus. 1999;8(3):197-209
10342712
Semin Cutan Med Surg. 1998 Sep;17(3):219-27
9759680
N Engl J Med. 1991 Jan 17;324(3):150-4
1984192
J Am Acad Dermatol. 2006 Sep;55(3):490-500
16908356
Rheumatology (Oxford). 2004 Mar;43(3):358-63
14623949
Ann N Y Acad Sci. 1975 Jun 30;254:505-15
52321